FDA Announces Proposed Collection of Information for Human Drug Compounding Outsourcing Facilities

Summary

The Food and Drug Administration (FDA) has submitted a proposed collection of information to the Office of Management and Budget (OMB) for review and clearance, related to the registration of human drug compounding outsourcing facilities under the Federal Food, Drug, and Cosmetic Act and associated fees.